Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The membrane attack complex (MAC) is a multiprotein complex formed by the sequential assembly of complement components C5b, C6, C7, C8, and multiple copies of C9. It forms transmembrane pores on target cell membranes, leading to osmotic lysis and cell death. While essential for defense against pathogens, dysregulated MAC activity can contribute to tissue injury in various diseases. It can also trigger pro-inflammatory signaling without cell lysis.
Therapeutic strategies targeting various stages/components/regulators are under investigation for treating these conditions by modulating MAC activity/signaling rather than complete inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component C5b-9 Membrane Attack Complex (MAC).